Clofazimine does not lead to significant QT interval prolongation: a multicentre study

التفاصيل البيبلوغرافية
العنوان: Clofazimine does not lead to significant QT interval prolongation: a multicentre study
المؤلفون: Zweijpfenning, SMH, van Groningen, H, van Ingen, J, Magis-Escurra, C, Boeree, MJ, Wagner, D, Bax, Hannelore, Andrejak, C, Wener, R, Rahman, A, Kunst, H, Lorent, N, Brouwer, MA, Hoefsloot, W, Ntm, NET
المساهمون: Internal Medicine
المصدر: European Respiratory Journal, 52(5):1801386. European Respiratory Society
European Respiratory Journal, 52, 5, pp. 1801386
European Respiratory Journal, 52, 1801386
سنة النشر: 2018
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, business.industry, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Prolongation, Arrhythmias, Cardiac, Heart, Clofazimine, QT interval, Long QT Syndrome, 03 medical and health sciences, lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], 0302 clinical medicine, 030228 respiratory system, Internal medicine, medicine, Cardiology, Humans, 030212 general & internal medicine, Diarylquinolines, Lead (electronics), business, medicine.drug
الوصف: Clofazimine does not lead to significant QT interval prolongation in the treatment of nontuberculous mycobacteriahttp://ow.ly/sXC330lIbI8
وصف الملف: application/pdf
تدمد: 0903-1936
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f528b4c0bddb5a44d7857b9066b30e6c
https://doi.org/10.1183/13993003.01386-2018
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....f528b4c0bddb5a44d7857b9066b30e6c
قاعدة البيانات: OpenAIRE